VIDEO: Reduced steroids, nonrestrictive diet may be more tolerable in multiple myeloma
Click Here to Manage Email Alerts
NEW ORLEANS — In this video perspective, Samer Al Hadidi, MD, MS, FACP, discusses presentations from the ASH Annual Meeting and Exposition that focus on treatments that yielded better tolerance for patients with multiple myeloma.
In one randomized phase 3 trial, initial therapy without steroids seemed comparable to the regimen that included steroids in older, frail patients with multiple myeloma, according to Al Hadidi, assistant professor at the University of Arkansas for Medical Sciences.
“This is important to try to tailor therapies for our patients,” he told Healio.
Another presentation of a randomized trial found that a nonrestrictive diet did not appear to increase the rates of infection after hematopoietic stem cells transplantation and were associated with better patient satisfaction, Al Hadidi said.
References:
- Manier S, et al. Abstract 569. Presented at: ASH Annual Meeting and Exposition; Dec. 10-13, 2022; New Orleans.
- Stella F, et al. Abstract 169. Presented at: ASH Annual Meeting and Exposition; Dec. 10-13, 2022; New Orleans.
Collapse
Healio Interviews
Read more about
Click Here to Manage Email Alerts